CCA Lipid Routing Tool
Cardiology Center of Amarillo
All Tools
⚠ In clinical review — do not use for patient care. The 10-year ASCVD risk shown here is now computed live from the AHA PREVENT™ equations(a rebuild of this tool’s risk engine), and the fast-path gate routing (live LDL-goal banner with early exit for clinical ASCVD, LDL ≥190, and diabetes age 40–75) is also new. Neither has been reviewed or signed off by a physician. Verify every output against the AHA PREVENT calculator and the 2026 ACC/AHA dyslipidemia guideline before acting. Reviewed: false.
Disclaimer: This tool is for clinician-supervised lipid result routing and documentation support only. It is not an autonomous prescribing tool and does not replace provider judgment. All medication starts, stops, dose changes, advanced lipid therapy decisions, and urgent result actions require review and approval by the responsible clinician unless a formal clinic-approved standing protocol is in place. Do not enter PHI.
Live LDL goal<100 mg/dLRisk discussion — statin if risk enhancers favor therapy

Step 1: Risk Profile

Optional initials only — do not enter PHI (full name, DOB, MRN, etc.)

Known clinical ASCVD (prior MI, stroke, PCI, CABG, PAD)?
Risk factors — check all that apply (unchecked = No)
ACC/AHA PREVENT™ 10-year risk (computed)

Enter the values below and the tool computes the 10-year ASCVD risk directly (AHA PREVENT equations, validated ages 30–79). Total cholesterol and HDL are pulled from Step 3 · Lipid Results.

Sex assigned at birth (PREVENT is sex-specific)
On BP-lowering medication?
Optional inputs (BMI, HbA1c, UACR) — refine the model
Awaiting inputs to compute risk — needs sex, age 30–79, systolic BP, eGFR, plus total cholesterol & HDL from Step 3. Outside age 30–79 or with labs missing, the tool falls back to the manual category below.
Manual PREVENT category (fallback — age outside 30–79 or labs unavailable)

Used only when the computed result above is unavailable.

Step 2: CAC Score

CAC (Coronary Artery Calcium) score available?
Incidental CAC on non-gated CT (chest CT, etc.)?

Step 3: Lipid Results

Non-HDL-C (auto-calculated): — (enter TC and HDL)= Total Cholesterol − HDL-C
LDL goal: <100 mg/dL — enter LDL to see distance
Prior LDL (for percent reduction calculation)

Step 4: Current Medications

Statin Therapy
Other statin:
Non-statin / Add-on Therapy
Other:
Medication Adherence

Step 5: Statin Tolerance / Refusal

Statin issues reported (check all that apply):
Step 6: Advanced Markers (Lp(a), ApoB — optional; mirrors Step 3 entries)

Advanced lipid markers help identify residual risk beyond LDL-C. These values mirror entries from the Lipid Results section.

Lipoprotein(a) — Lp(a)

Lp(a) ≥50 mg/dL or ≥125 nmol/L is elevated. Largely genetically determined; not responsive to statins. The 2026 ACC/AHA dyslipidemia guideline recommends measuring at least once in adulthood.

Apolipoprotein B (ApoB)

ApoB reflects total atherogenic particle burden. Especially useful when TG is elevated, patient has diabetes, or metabolic syndrome.

The LDL goal and recommendation update live in the banner above — click to build the documentation outputs (provider task, patient message, checklists)

Disclaimer 1: This tool is for clinician-supervised lipid result routing and documentation support only. It is not an autonomous prescribing tool and does not replace provider judgment. All medication starts, stops, dose changes, advanced lipid therapy decisions, and urgent result actions require review and approval by the responsible clinician unless a formal clinic-approved standing protocol is in place. Do not enter PHI.

Disclaimer 2: Guideline logic reflects the 2026 ACC/AHA/Multisociety dyslipidemia guideline (PREVENT risk equations; restored LDL-C goals of <55 for very-high-risk ASCVD, <70 for clinical ASCVD and high-risk primary prevention, and <100 for borderline/intermediate primary prevention). It is simplified for clinic workflow and should be verified against the full guideline, local clinic protocols, payer requirements, and supervising physician preferences.

CCA Lipid Routing Tool — Cardiology Center of Amarillo — For clinician-supervised use only